Search results
1 company and 6 research reports found for "DiaSorin"
Company results
- DiaSorin
DaiSorin is a leading manufacturer of in vitro diagnostic tests, a €7bn global market. Sales i...
Sector reports
No sector reports have been found.
Research results
Stratec Biomedical
Two growth scenarios
QuickView | Pharmaceutical & Healthcare | 17/05/2012Stratec’s new guidance shows uncertainties over 2012 associated with the ongoing Gen-Probe acquisition by Hologic; the FDA has approved the Pant...
Immunodiagnostic Systems Holdings
A testing moment
QuickView | Pharmaceutical & Healthcare | 29/11/2011Peaking at 1,219p on 25 July, the market has now diagnosed a weaker outlook than earlier exuberance had priced in after strong FY11 results. Growth ap...
Stratec Biomedical
Growth potential
QuickView | Pharmaceutical & Healthcare | 08/11/2011Q3 earnings statements from Stratec and its customer Gen-Probe emphasise the growth potential in newly-launched products. This adds to projections fro...
DiaSorin
Vitamin D as a cash cow
QuickView | Pharmaceutical & Healthcare | 20/10/2011DiaSorin’s roadshow showcased new tests, mostly due late 2012. R&D is focused on new immunoassays, including a novel faeces testing widget, and ...
Stratec Biomedical
Sunshine at Stratec
QuickView | Pharmaceutical & Healthcare | 05/10/2011Stratec’s strength is design, logistics and assembly of sophisticated diagnostic OEM systems (customers supply their chemistry). It offers high-...
Immunodiagnostic Systems Holdings
Highly rated bet
QuickView | Pharmaceutical & Healthcare | 14/07/2010Strong growth continues with organic sales increasing by £10.9m (up 43%) giving £37.16m overall (including £1.3m currency). FDA approval of iSYS on...
